Models contend iodine double bonds


I-O bonds within the periodate ion are usually represented as double bonds (left), but AdNDP suggests they are dative (right) © Wiley-VCH

Hypervalent iodine reagents are widely used in organic synthesis, but their structures haven’t been studied in detail. In the majority of textbooks and papers, they are drawn with double bonds between iodine and oxygen, nitrogen or carbon.

But a new study has used theoretical models to show that this might be incorrect. Instead, it suggests the bonds within some of these compounds are dative, with iodine donating the electron pair.

A team led by Alexander Boldyrev and Viktor Zhdankin at Utah State University in the US examined the nature of the bonds within compounds such as iodosylbenzene (PhIO) and the periodate ion (IO4-) using a bond modelling technique called adaptive natural density partitioning (AdNDP). Their calculations revealed the bonds to be dative rather than double.

The group says the discovery will be useful when it comes to understanding reaction mechanisms, and suggests the textbooks may need correcting.

References

A S Ivanov et al, Angew. Chem. Int. Ed., 2014, DOI: 10.1002/anie.201405142


Related Content

What is a bond?

30 January 2014 Premium contentFeature

news image

There’s more to bonding than covalent, ionic and the lines we draw between atoms on paper. Philip Ball takes on the expandi...

What we mean when we talk about bonds

29 January 2015 Comments

news image

Santiago Alvarez delves into the debates and disagreements that surround one of chemistry's most fundamental concepts

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Chemists zinc up ‘aromatic’ metal cubes

2 March 2015 Research

news image

Metal-organic clusters share electrons between eight covalently linked metal atoms

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent